Wockhardt Amends Rs 1,850 Crore Deal With Dr. Reddy’s To Assess Covid-19 Impact
A group of multicolored tablets for medical treatment are arranged for a photograph at a pharmacy. (Photographer: Dimas Ardian/Bloomberg)

Wockhardt Amends Rs 1,850 Crore Deal With Dr. Reddy’s To Assess Covid-19 Impact

The board of Wockhardt Ltd. approved an amendment to a Rs 1,850-crore deal with Dr. Reddy’s Laboratories Ltd. for sale of select divisions of the Mumbai-based drugmaker’s branded generics business ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.